PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.05 Billion KRW | -94.75% |
| 2022 | 20.13 Billion KRW | 40.3% |
| 2021 | 14.35 Billion KRW | 418.09% |
| 2020 | -4.51 Billion KRW | -153.81% |
| 2019 | 8.38 Billion KRW | 372.08% |
| 2018 | -3.08 Billion KRW | 37.77% |
| 2017 | -4.95 Billion KRW | -201.57% |
| 2016 | 4.87 Billion KRW | 506.26% |
| 2015 | 804.27 Million KRW | -88.07% |
| 2014 | 6.74 Billion KRW | 65.52% |
| 2013 | 4.07 Billion KRW | 404.47% |
| 2012 | 807.29 Million KRW | -92.38% |
| 2011 | 10.58 Billion KRW | -37.54% |
| 2010 | 16.95 Billion KRW | -5.42% |
| 2009 | 17.92 Billion KRW | -41.96% |
| 2008 | 30.88 Billion KRW | 11.57% |
| 2007 | 27.67 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 3.39 Billion KRW | 23.84% |
| 2024 Q1 | 2.73 Billion KRW | 158.98% |
| 2023 Q2 | 15.7 Billion KRW | -35.98% |
| 2023 Q3 | 16.52 Billion KRW | 5.19% |
| 2023 FY | 1.05 Billion KRW | -94.75% |
| 2023 Q1 | 24.53 Billion KRW | 21.83% |
| 2023 Q4 | 1.05 Billion KRW | -93.6% |
| 2022 Q3 | 21.82 Billion KRW | 5.8% |
| 2022 Q4 | 20.13 Billion KRW | -7.73% |
| 2022 FY | 20.13 Billion KRW | 40.3% |
| 2022 Q2 | 20.62 Billion KRW | 95.68% |
| 2022 Q1 | 10.54 Billion KRW | -26.56% |
| 2021 Q2 | 15.93 Billion KRW | 581.19% |
| 2021 Q4 | 14.35 Billion KRW | -27.37% |
| 2021 FY | 14.35 Billion KRW | 418.09% |
| 2021 Q3 | 19.76 Billion KRW | 24.04% |
| 2021 Q1 | 2.33 Billion KRW | 151.84% |
| 2020 FY | -4.51 Billion KRW | -153.81% |
| 2020 Q2 | -2.49 Billion KRW | -208.98% |
| 2020 Q1 | 2.28 Billion KRW | -72.72% |
| 2020 Q4 | -4.51 Billion KRW | 31.64% |
| 2020 Q3 | -6.6 Billion KRW | -164.81% |
| 2019 Q2 | 12 Billion KRW | -5.25% |
| 2019 FY | 8.38 Billion KRW | 372.08% |
| 2019 Q4 | 8.38 Billion KRW | -38.18% |
| 2019 Q3 | 13.56 Billion KRW | 12.93% |
| 2019 Q1 | 12.67 Billion KRW | 511.29% |
| 2018 Q3 | -6.5 Billion KRW | -2.84% |
| 2018 FY | -3.08 Billion KRW | 37.77% |
| 2018 Q1 | -6.26 Billion KRW | -26.56% |
| 2018 Q2 | -6.32 Billion KRW | -0.91% |
| 2018 Q4 | -3.08 Billion KRW | 52.62% |
| 2017 Q4 | -4.95 Billion KRW | 15.07% |
| 2017 FY | -4.95 Billion KRW | -201.57% |
| 2017 Q1 | -2.92 Billion KRW | -159.92% |
| 2017 Q2 | -4.78 Billion KRW | -63.85% |
| 2017 Q3 | -5.83 Billion KRW | -21.82% |
| 2016 Q2 | 8.21 Billion KRW | 1328.76% |
| 2016 FY | 4.87 Billion KRW | 506.26% |
| 2016 Q3 | 7.59 Billion KRW | -7.57% |
| 2016 Q1 | -668.6 Million KRW | -183.13% |
| 2016 Q4 | 4.87 Billion KRW | -35.79% |
| 2015 Q4 | 804.27 Million KRW | 194.65% |
| 2015 Q3 | -849.76 Million KRW | 34.49% |
| 2015 FY | 804.27 Million KRW | -88.07% |
| 2015 Q1 | 5.91 Billion KRW | -12.29% |
| 2015 Q2 | -1.29 Billion KRW | -121.94% |
| 2014 Q3 | 8.86 Billion KRW | 26.71% |
| 2014 Q4 | 6.74 Billion KRW | -23.96% |
| 2014 Q2 | 6.99 Billion KRW | 105.42% |
| 2014 Q1 | 3.4 Billion KRW | -16.37% |
| 2014 FY | 6.74 Billion KRW | 65.52% |
| 2013 Q3 | 3.4 Billion KRW | 23.49% |
| 2013 FY | 4.07 Billion KRW | 404.47% |
| 2013 Q1 | 1.91 Billion KRW | 137.17% |
| 2013 Q2 | 2.75 Billion KRW | 44.09% |
| 2013 Q4 | 4.07 Billion KRW | 19.54% |
| 2012 Q2 | 7.69 Billion KRW | -21.19% |
| 2012 Q1 | 9.76 Billion KRW | -7.75% |
| 2012 FY | 807.29 Million KRW | -92.38% |
| 2012 Q4 | 807.29 Million KRW | 176.33% |
| 2012 Q3 | -1.05 Billion KRW | -113.74% |
| 2011 FY | 10.58 Billion KRW | -37.54% |
| 2011 Q2 | 16.55 Billion KRW | -17.66% |
| 2011 Q1 | 20.1 Billion KRW | 18.58% |
| 2011 Q4 | 10.58 Billion KRW | -29.17% |
| 2011 Q3 | 14.94 Billion KRW | -9.69% |
| 2010 FY | 16.95 Billion KRW | -5.42% |
| 2010 Q1 | 18 Billion KRW | 0.44% |
| 2010 Q2 | 16.82 Billion KRW | -6.54% |
| 2010 Q3 | 17.19 Billion KRW | 2.19% |
| 2010 Q4 | 16.95 Billion KRW | -1.4% |
| 2009 Q2 | 21.91 Billion KRW | -28.3% |
| 2009 Q1 | 30.56 Billion KRW | -1.01% |
| 2009 Q4 | 17.92 Billion KRW | -32.62% |
| 2009 Q3 | 26.59 Billion KRW | 21.36% |
| 2009 FY | 17.92 Billion KRW | -41.96% |
| 2008 Q3 | 36.45 Billion KRW | 17.36% |
| 2008 Q2 | 31.06 Billion KRW | 5.97% |
| 2008 FY | 30.88 Billion KRW | 11.57% |
| 2008 Q4 | 30.88 Billion KRW | -15.29% |
| 2008 Q1 | 29.31 Billion KRW | 5.9% |
| 2007 Q2 | 16.58 Billion KRW | -25.73% |
| 2007 Q4 | 27.67 Billion KRW | 17.92% |
| 2007 Q3 | 23.47 Billion KRW | 41.53% |
| 2007 FY | 27.67 Billion KRW | 0.0% |
| 2007 Q1 | 22.33 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Daewoong Co., Ltd. | 315.57 Billion KRW | 99.665% |
| Wooridul Huebrain Limited | -16.72 Billion KRW | 106.324% |